HYPERBARIC OXYGEN THERAPY FOR PYODERMA GANGRENOSUM
- 1 October 1984
- journal article
- research article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 14 (5) , 618-621
- https://doi.org/10.1111/j.1445-5994.1984.tb05011.x
Abstract
Hyperbaric O2 administered systemically was advocated in the treatment of pyoderma gangrenosum. Owing to the serious potential risks of O2 toxicity with systemic administration, a simplified technique was devised for the administration of hyperbaric O2 topically. This method was used successfully to treat 2 patients with pyoderma gangrenosum, in whom the underlying etiology was not apparent and specific therapy, therefore, not possible. The abundant formation of granulation tissue and the ability of the hyperbaric O2 to arrest further extension of the ulceration suggests that this form of therapy might become the treatment of choice for all ulcers of the pyoderma gangrenosum type.Keywords
This publication has 21 references indexed in Scilit:
- Pyoderma gangrenosum. Occurrence with altered cellular immunity and a circulating serum factorArchives of Dermatology, 1982
- PYODERMA GANGRENOSUM: A REAPPRAISAL OF ASSOCIATED SYSTEMIC DISEASESBritish Journal of Dermatology, 1980
- The Lung and Oxygen ToxicityArchives of internal medicine (1960), 1979
- Pyoderma gangrenosum. Abnormal monocyte function corrected in vitro with hydrocortisoneArchives of Dermatology, 1978
- Pyoderma Gangrenosum Associated with Regional EnteritisActa Medica Scandinavica, 1977
- Sulfapyridine and Sulfone Type Drugs in DermatologyArchives of Dermatology, 1962
- Surgical and physiological observations in an experimental pressure chamberBritish Journal of Surgery, 1961
- Studies of the reaction between methylene blue and living cells and tissues in the transparent moat chamber introduced into the rabbit's earThe Anatomical Record, 1934